Does reduced morning HPA output, CRHR1 signaling differences, 11β-HSD1 tissue cortisol regeneration, menopausal estrogen decline, and inflammatory signaling reduce cortisol rhythm resilience?

Maintaining a resilient diurnal cortisol rhythm requires a precise balance of central hypothalamic-pituitary-adrenal (HPA) feedback, local tissue-level enzymatic conversion, and systemic ovarian hormone regulation. During the menopausal transition, these interconnected systems can destabilize, flattening the diurnal curve and reducing stress resilience.

Mechanistic pathways of rhythm disruption

• Genetic receptor variations: Central HPA axis reactivity and the cortisol awakening response (CAR) are heavily influenced by genetic variations in the corticotropin-releasing hormone receptor 1 (CRHR1) gene, such as the rs110402 polymorphism, which alter peak morning cortisol output.
• Local tissue regeneration: The HSD11B1 gene encodes the 11β-HSD1 enzyme, which converts inactive cortisone into active cortisol within peripheral tissues. Common polymorphisms, including rs12086634, alter this local regeneration and systemic clearance, directly impacting salivary cortisol availability and diurnal curve trajectory.

Endocrine-immune destabilization

• Loss of estrogenic HPA feedback: Estrogen serves as a primary regulatory brake on the HPA axis by modulating stress-induced ACTH and cortisol release. The menopausal decline of 17β-estradiol removes this "dimmer switch," leading to erratic HPA axis reactivity.
• Pro-inflammatory cascade: Depleted estrogen levels relieve the typical physiological inhibition of the NF-κB pathway. This leads to a systemic up-regulation of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Without estrogenic restraint, these elevated cytokines continuously stimulate the HPA axis, driving glucocorticoid receptor resistance and flattening the diurnal cortisol slope.

Bottom line

• For a menopausal female, genetic variations in CRHR1 and HSD11B1 systematically converge with estrogen-loss-driven pro-inflammatory signaling (via NF-κB, IL-6, and TNF-α) to erode HPA feedback control, blunting the morning cortisol awakening response and flattening the diurnal curve.